The Captial Market (CapitalMarket.com) rating for Laurus Labs IPO is 40. Their analysis recommends Avoid, However active risk seekers can try for the IPO.

Reviewer	Rating Score	Rating
Capital Market	40	Avoid, However active risk seekers can try

Laurus Labs IPO Review by Dilip Davda (Apply)

[Dilip Davda] Company is having good contracts from world leaders and enjoys leadership position in APIs and generics. Investments made by the company will start adding to revenues and profits from FY 18 onwards and thus poised for bright prospects. Although issue appears to have been priced in line with peer’s trending, it may be considered for medium to long term investment. Read detail review...

Laurus Labs IPO Review by Members

Laurus Labs IPO Reviews, analysis and views by popular members. Read Laurus Labs Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Laurus Labs IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Laurus Labs IPO Review & Recommendations

Laurus Labs IPO Review Summary from brokers and analysts

Laurus Labs IPO Capital Market Rating

Laurus Labs IPO Review by Dilip Davda (Apply)

Laurus Labs IPO Review by Members

Laurus Labs IPO Review Summary by Members

Read more about Laurus Labs IPO